Can medical aesthetic treatments improve mental health?
2023; Mark Allen Group; Volume: 12; Issue: 1 Linguagem: Inglês
10.12968/joan.2023.12.1.30
ISSN2052-2878
Autores Tópico(s)Empathy and Medical Education
ResumoJournal of Aesthetic NursingVol. 12, No. 1 ProfessionalCan medical aesthetic treatments improve mental health?Kimberley CairnsKimberley CairnsE: E-mail Address: [email protected]Specialist Integrative Psychologist and Director of the Integrated Practitioners of Aesthetic WellnessSearch for more papers by this authorKimberley CairnsPublished Online:1 Feb 2023https://doi.org/10.12968/joan.2023.12.1.30AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References All Party Parliamentary Group for Beauty and Welling. Inquiry into the value of complimentary therapies. 2023. https://tinyurl.com/53zeafra (accessed 23 January 2023) Google ScholarBell R. Psychosocial pathways and health outcomes. Public Health England. 2017. https://tinyurl.com/yxkh8uut (accessed 23 January 2023) Google ScholarCosta ACF, Silva ECD, Gondim DV. Botulinum toxin in facial aesthetics affects the emotion process: a meta-analysis of randomized controlled trials. Clin Psychopharmacol Neurosci. 2022;20(4):600–608. https://doi.org/10.9758/cpn.2022.20.4.600 Crossref, Google ScholarCuijpers P, Noma H, Karyotaki E et al.. A network meta-analysis of psychotherapy, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020;19(1):92–107. https://doi.org/10.1002/wps.20701 Crossref, Google ScholarDepartment of Health and Social Care. Call for evidence for new 10-year plan to improve mental health. 2022. https://tinyurl.com/2p97hayu (accessed 23 January 2023) Google ScholarDressler D, Adib Saberi F. Botulinum toxin: mechanisms of action. Eur Neurol. 2005;53(1):3–9. https://doi.org/10.1159/000083259 Crossref, Google ScholarEkman P. Darwin's contributions to our understanding of emotional expressions. Philos Trans R Soc Lond B Biol Sci. 2009;364(1535):3449–3451. https://doi.org/10.1098/rstb.2009.0189 Crossref, Google ScholarFinzi E, Rosenthal NE. Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res. 2014;52:1–6. https://doi.org/10.1016/j.jpsychires.2013.11.006 Crossref, Google ScholarFinzi E, Wasserman E. Treatment of depression with botulinum toxin A: a case series. Dermatol Surg. 2006;32(5):645–649. https://doi.org/10.1111/j.1524-4725.2006.32136.x Google ScholarHexsel D, Brum C, Siega C et al.. Evaluation of self-esteem and depression symptoms in depressed and nondepressed subjects treated with onabotulinumtoxinA for glabella lines. Dermatol Surg. 2013;39(7):1088–1096. https://doi.org/10.1111/dsu.12175 Crossref, Google ScholarJoint Council for Cosmetic Practitioners (JCCP). What constitutes a medical, medically related or cosmetic procedure. 2021. https://tinyurl.com/bdupacc4 (accessed 23 January 2023) Google ScholarKim MJ, Neta M, Davis FC et al.. Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design. Biol Mood Anxiety Disord. 2014;4:11. https://doi.org/10.1186/2045-5380-4-11 Crossref, Google ScholarKruger THC, Schulze J, Bechinie A et al.. Neuronal effects of glabella botulinum toxin injections using a valenced inhibition task in borderline personality disorder. Sci Rep. 2022;12:14197. https://doi.org/10.1038/s41598-022-17509-0 Crossref, Google ScholarLewis MB. The interactions between botulinum-toxin-based facial treatments and embodied emotions. Sci Rep. 2018;8:14720. https://doi.org/10.1038/s41598-018-33119-1 Crossref, Google ScholarLi GF, Ban S, Wang M et al.. Brain functional changes in patients with botulism after illegal cosmetic injections of botulinum toxin: a resting-state fMRI study. PLoS One. 2018;13(11):e0207448. https://doi.org/10.1371/journal.pone.0207448 Crossref, Google ScholarLozano R, Naghavi M, Foreman K et al.. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden Of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. https://doi.org/10.1016/s0140-6736(12)61728-0] Crossref, Google ScholarMagid M, Reichenberg JS, Poth PE et. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2014;75(8):837–844. https://doi.org/10.4088/JCP.13m08845 Crossref, Google ScholarMakunts T, Wollmer MA, Abagyan R. Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites. Sci Rep. 2020;10:12851. https://doi.org/10.1038/s41598-020-69773-7 Crossref, Google ScholarMedicines and Healthcare products Regulatory Agency. Yellow Card. 2023. https://yellowcard.mhra.gov.uk/ (accessed 23 January 2023) Google ScholarMind. Mental health problems – an introduction. 2023. https://tinyurl.com/yc43amab (accessed 23 January 2023) Google ScholarNational Institute for Health and Care Excellence. Clinical guidance: common mental health problems, identification and pathways to care. 2011. www.nice.org.uk/guidance/cg123 (accessed 23 January 2023) Google ScholarNational Institute for Health and Care Excellence. Clinical guidance: depression diagnosis. 2022. https://cks.nice.org.uk/topics/depression/#!topicSummary (accessed 23 January 2023) Google ScholarSocial Care institute for Excellence. SCIE introduction to adult mental health services. 2012. https://tinyurl.com/uhyem8fw (accessed 23 January 2023) Google ScholarStrack F, Martin LL, Stepper S. Inhibiting and facilitating conditions of the human smile: a non obtrusive test of the facial feedback hypothesis. J Personality Soc Psychol. 1988;54(5):768–777. https://doi.org/10.1037/0022-3514.54.5.768 Crossref, Google ScholarUniversity College London. New national survey looking at individual patient experiences of botulinum toxin complications now launched. 2023. https://tinyurl.com/2k2vttxx (accessed 23 January 2023) Google ScholarVos T, Barber RM, Bell B et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2013;386(9995):743–800. https://doi.org/10.1016/S0140-6736(15)60692-4 Crossref, Google ScholarWeber A, Heger S, Sinkgraven R et al.. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol. 2005;152(2):342–345. https://doi.org/10.1111/j.1365-2133.2004.06334.x Crossref, Google ScholarWhiteford HA, Degenhardt L, Rehm J et al.. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382(9904):1575–1586. https://doi.org/10.1016/s0140-6736(13)61611-6 Crossref, Google ScholarWollmer MA, de Boer C, Kalak N et al.. Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res. 2012;46(5):574–581. https://doi.org/10.1016/j.jpsychires.2012.01.027 Crossref, Google ScholarWollmer MA, Makunts T, Krüger THC et al.. Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety. Sci Rep. 20211; 1:24173. https://doi.org/10.1038/s41598-021-03713-x Crossref, Google ScholarWorld Health Organization. Strengthening mental health promotion. Geneva: World Health Organization; 2001 Google ScholarZamanian A, Ghanbari Jolfaei A, Mehran G, Azizian Z. Efficacy of botox versus placebo for treatment of patients with major depression. Iran J Public Health. 2017;46(7):982–984 Google Scholar FiguresReferencesRelatedDetails 2 February 2023Volume 12Issue 1ISSN (print): 2050-3717ISSN (online): 2052-2878 Metrics History Published online 1 February 2023 Published in print 2 February 2023 Information© MA Healthcare LimitedPDF download
Referência(s)